Research Article
Integrated Bioinformatic Analysis Identifies TIPIN as a Prognostic Biomarker in Hepatocellular Carcinoma
Table 2
The relationship between TIPIN expression and the clinicopathological features of HCC in TMA.
| Clinicopathological features | No. of cases (%) | TIPIN expression level | value | Low | High |
| Age (years) | ≤55 | 40 | 20 | 20 | 0.068 | >55 | 40 | 12 | 28 | Gender | Female | 17 | 10 | 7 | 0.074 | Male | 63 | 22 | 41 | Pathogenesis | HBV | 58 | 21 | 37 | 0.261 | Other | 22 | 11 | 11 | ALT (U/L) | ≤35 | 48 | 20 | 28 | 0.709 | >35 | 32 | 12 | 20 | AST (U/L) | ≤31 | 42 | 15 | 27 | 0.411 | >31 | 38 | 17 | 21 | TB (U/L) | ≤12 | 43 | 18 | 25 | 0.714 | >12 | 37 | 14 | 13 | ALB (G/L) | ≤40 | 47 | 18 | 29 | 0.711 | >40 | 33 | 14 | 19 | TNM | I and II | 59 | 30 | 29 | 0.002 | III and IV | 21 | 2 | 19 | Tumor size | ≤5 cm | 40 | 18 | 22 | 0.361 | >5 cm | 40 | 14 | 26 |
|
|
TIPIN: TIM-interacting protein; ALT: alanine amiotransferase; AST: aspartate transaminase; TB: total bilirubin; ALB: albumin; TNM: tumor node metastasis; . |